Evidence map›Paper›PMID 30379932›Full record

ArticlePLoS pathogens2018

Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.

Isaac J Jensen, Christina S Winborn, Micaela G Fosdick, Peng Shao, Mikaela M Tremblay, Qiang Shan, Sandeep Kumar Tripathy, Christopher M Snyder, Hai-Hui Xue, Thomas S Griffith and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. The Dual Role of Natural Killer Cells in the Septic Liver.Journal of inflammation research · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Review
  11. Lymphopenia in sepsis: a narrative review.Critical care (London, England) · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Isaac J JensenInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0002-3107-3961
Christina S WinbornDepartment of Pathology, University of Iowa, Iowa City, Iowa, United States of America.
Micaela G FosdickInterdisciplinary Graduate Program in Molecular Medicine, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0002-2427-532X
Peng ShaoDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.
Mikaela M TremblayDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0001-9952-5381
Qiang ShanDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.
Sandeep Kumar TripathyGastroenterology Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Christopher M SnyderDepartment of Immunology and Microbiology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0003-1370-7198
Hai-Hui XueInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0002-9163-7669
Thomas S GriffithMicrobiology, Immunology, and Cancer Biology Ph.D. Program, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-7205-9859
Jon C HoutmanInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.
Vladimir P BadovinacInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0003-3180-2439
University of Iowa · USThomas Jefferson University · USUniversity of Minnesota · USWashington University in St. Louis · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
Tcf/Lef-b-catenin in T cell identity and cancerR01AI112579 · NIAID · UNIVERSITY OF IOWA · PI Hai-Hui Xue · 2015 to 2026
$5.4M
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Tcf/Lef and B-catenin pathway in follicular helper T cellsR01AI121080 · NIAID · UNIVERSITY OF IOWA · PI Hai-Hui Xue · 2016 to 2026
$4.6M
Memory CD8 T cell localization and protection from influenzaR01AI114543 · NIAID · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P, HARTY, JOHN T · 2015 to 2024
$4.4M
MECHANISMS OF NATURAL KILLER CELL TOLERANCER01AI089870 · NIAID · WASHINGTON UNIVERSITY · PI TRIPATHY, SANDEEP KUMAR · 2011 to 2014
$1.5M
Alterations in CD4 T cells during sepsisR01GM115462 · NIGMS · UNIVERSITY OF MINNESOTA · PI GRIFFITH, THOMAS S · 2016 to 2019
$1.2M
Impairment and recovery of CD8 T cell responses after sepsisR01GM113961 · NIGMS · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P · 2015 to 2018
$1.2M
The role of HCV RNA-targeted phosphatase PTPRE in T cell activationR56AI126493 · NIAID · UNIVERSITY OF IOWA · PI HOUTMAN, JON C.D., STAPLETON, JACK T. · 2017 to 2017
$538k
Targeting Tcf/Lef-transcriptional program in leukemic stem cellsI01BX002903 · VA · VA NEW JERSEY HEALTH CARE SYSTEM · PI XUE, HAI-HUI · 2016 to 2019
–
BLRD VA I01 BX001324BLRD VA I01 BX002903NCI NIH HHS P30 CA086862NIAID NIH HHS R01 AI089870NIAID NIH HHS R01 AI112579NIAID NIH HHS R01 AI114543NIAID NIH HHS R01 AI121080NIAID NIH HHS R56 AI126493NIAID NIH HHS T32 AI007485NIAID NIH HHS T32 AI007511NIGMS NIH HHS R01 GM113961NIGMS NIH HHS R01 GM115462
6 · The paper itself

Abstract

The sepsis-induced cytokine storm leads to severe lymphopenia and reduced effector capacity of remaining/surviving cells. This results in a prolonged state of immunoparalysis, that contributes to enhanced morbidity/mortality of sepsis survivors upon secondary infection. The impact of sepsis on several lymphoid subsets has been characterized, yet its impact on NK-cells remains underappreciated-despite their critical role in controlling infection(s). Here, we observed numerical loss of NK-cells in multiple tissues after cecal-ligation-and-puncture (CLP)-induced sepsis. To elucidate the sepsis-induced lesions in surviving NK-cells, transcriptional profiles were evaluated and indicated changes consistent with impaired effector functionality. A corresponding deficit in NK-cell capacity to produce effector molecules following secondary infection and/or cytokine stimulation (IL-12,IL-18) further suggested a sepsis-induced NK-cell intrinsic impairment. To specifically probe NK-cell receptor-mediated function, the activating Ly49H receptor, that recognizes the murine cytomegalovirus (MCMV) m157 protein, served as a model receptor. Although relative expression of Ly49H receptor did not change, the number of Ly49H+ NK-cells in CLP hosts was reduced leading to impaired in vivo cytotoxicity and the capacity of NK-cells (on per-cell basis) to perform Ly49H-mediated degranulation, killing, and effector molecule production in vitro was also severely reduced. Mechanistically, Ly49H adaptor protein (DAP12) activation and clustering, assessed by TIRF microscopy, was compromised. This was further associated with diminished AKT phosphorylation and capacity to flux calcium following receptor stimulation. Importantly, DAP12 overexpression in NK-cells restored Ly49H/D receptors-mediated effector functions in CLP hosts. Finally, as a consequence of sepsis-dependent numerical and functional lesions in Ly49H+ NK-cells, host capacity to control MCMV infection was significantly impaired. Importantly, IL-2 complex (IL-2c) therapy after CLP improved numbers but not a function of NK-cells leading to enhanced immunity to MCMV challenge. Thus, the sepsis-induced immunoparalysis state includes numerical and NK-cell-intrinsic functional impairments, an instructive notion for future studies aimed in restoring NK-cell immunity in sepsis survivors.

Indexed as

AnimalsCells, CulturedCytokinesCytomegalovirus InfectionsImmunity, CellularKiller Cells, NaturalMiceMice, Inbred C57BLMice, KnockoutMuromegalovirusNK Cell Lectin-Like Receptor Subfamily APerforinSepsisCytokinesNK Cell Lectin-Like Receptor Subfamily APerforinperforin 1, mouse

Identifiers

PMID30379932
PMCPMC6231673
OpenAlexW2898849131

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.